BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 17157756)

  • 1. A randomized, double-blind, crossover trial of the effect of oxygen on dyspnea in patients with advanced cancer.
    Philip J; Gold M; Milner A; Di Iulio J; Miller B; Spruyt O
    J Pain Symptom Manage; 2006 Dec; 32(6):541-50. PubMed ID: 17157756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Symptomatic treatment of dyspnoea in patients receiving palliative care: nasal delivery of oxygen compared with opioid administration].
    Clemens KE; Klaschik E
    Dtsch Med Wochenschr; 2007 Sep; 132(38):1939-43. PubMed ID: 17853348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relief of incident dyspnea in palliative cancer patients: a pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline.
    Charles MA; Reymond L; Israel F
    J Pain Symptom Manage; 2008 Jul; 36(1):29-38. PubMed ID: 18358689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial of supplemental oxygen versus air in cancer patients with dyspnea.
    Bruera E; Sweeney C; Willey J; Palmer JL; Strasser F; Morice RC; Pisters K
    Palliat Med; 2003 Dec; 17(8):659-63. PubMed ID: 14694916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxygen for relief of dyspnea: what is the evidence?
    Uronis HE; Abernethy AP
    Curr Opin Support Palliat Care; 2008 Jun; 2(2):89-94. PubMed ID: 18685402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Symptomatic relief in dyspnoea].
    Jespersen BA; Salomonsen A; Rasmussen TR
    Ugeskr Laeger; 2007 Oct; 169(44):3756-9. PubMed ID: 18028843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine for dyspnea control in terminal cancer patients: is it appropriate in Taiwan?
    Hu WY; Chiu TY; Cheng SY; Chen CY
    J Pain Symptom Manage; 2004 Oct; 28(4):356-63. PubMed ID: 15471653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients.
    Clemens KE; Klaschik E
    J Pain Symptom Manage; 2007 Apr; 33(4):473-81. PubMed ID: 17397708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.
    Jensen D; Amjadi K; Harris-McAllister V; Webb KA; O'Donnell DE
    Thorax; 2008 Jul; 63(7):606-13. PubMed ID: 18250181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence and treatment of air hunger in severely ill patients.
    Shumway NM; Wilson RL; Howard RS; Parker JM; Eliasson AH
    Respir Med; 2008 Jan; 102(1):27-31. PubMed ID: 17935962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methylphenidate in palliative care in cancer patient: a double-blind randomised trial versus placebo].
    Laval G; Paris A
    Bull Cancer; 2008 Feb; 95(2):241-6. PubMed ID: 18304907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study.
    Bruera E; Sala R; Spruyt O; Palmer JL; Zhang T; Willey J
    J Pain Symptom Manage; 2005 Jun; 29(6):613-8. PubMed ID: 15963870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ambulatory oxygen on exertional dyspnea in IPF patients without resting hypoxemia.
    Nishiyama O; Miyajima H; Fukai Y; Yamazaki R; Satoh R; Yamagata T; Sano H; Iwanaga T; Higashimoto Y; Nakajima H; Kume H; Tohda Y
    Respir Med; 2013 Aug; 107(8):1241-6. PubMed ID: 23806287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: relief of incident dyspnea in palliative cancer patients.
    Cuervo Pinna MA
    J Pain Symptom Manage; 2008 Oct; 36(4):e5-6. PubMed ID: 18922379
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
    Kress HG; OroĊ„ska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
    Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised, placebo controlled trial of nebulised furosemide for breathlessness in patients with cancer.
    Wilcock A; Walton A; Manderson C; Feathers L; El Khoury B; Lewis M; Chauhan A; Howard P; Bell S; Frisby J; Tattersfield A
    Thorax; 2008 Oct; 63(10):872-5. PubMed ID: 18408049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of inhaled opioids and furosemide for the treatment of dyspnea.
    Kallet RH
    Respir Care; 2007 Jul; 52(7):900-10. PubMed ID: 17594733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic intervention for cancer-related dyspnea.
    Cuervo Pinna MA; Mota Vargas R; Redondo Moralo MJ; Correas MA
    J Clin Oncol; 2008 Sep; 26(25):4225; author reply 4226. PubMed ID: 18757344
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperbaric oxygen treatment of chronic refractory radiation proctitis: a randomized and controlled double-blind crossover trial with long-term follow-up.
    Clarke RE; Tenorio LM; Hussey JR; Toklu AS; Cone DL; Hinojosa JG; Desai SP; Dominguez Parra L; Rodrigues SD; Long RJ; Walker MB
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):134-143. PubMed ID: 18342453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The experience of dyspnea in late-stage cancer. Patients' and nurses' perspectives.
    Roberts DK; Thorne SE; Pearson C
    Cancer Nurs; 1993 Aug; 16(4):310-20. PubMed ID: 7691396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.